Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02033642 · ClinicalTrials.gov registry record · NA

A Family-Based Weight Loss Intervention for Youth With Intellectual Disability

A NA study of Obesity, sponsored by University of Massachusetts, Boston.

Completed
Registry status
NA
Development phase
31
Enrollment target
1
Study location

NCT02033642: Completed NA study of Obesity, sponsored by University of Massachusetts, Boston.

NCT02033642 is a NA study of Obesity that has completed, run by University of Massachusetts, Boston. The registered enrollment target is 31 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02033642, a NA study of Obesity, has completed, sponsored by University of Massachusetts, Boston.

COMPLETED
Registry status
NA
Development phase
31 participants
Enrollment target
1
Study location

Study Summary

The purpose of this randomized controlled trial is twofold. First, to examine the efficacy of a 24-session, 6-month family-based behavioral intervention (FBBI) - as compared to a waitlist FBBI group, which later receives the same FBBI - that targets weight loss in adolescents/young adults with intellectual disability aged 14-22 years. Second, to examine the efficacy of a 12-session, 6-month Maintenance intervention that targets maintenance of weight loss in the same population of adolescents/young adults with intellectual disability. The Maintenance condition follows the completion of each FBBI group and involves a re-randomization to either the Maintenance intervention or no further intervention. Primary outcome measures include body weight and Body Mass Index (BMI). Secondary outcome measures include physical activity/sedentary behavior (measured via accelerometry), dietary patterns (3-Day Food Records), and self-efficacy (brief questionnaire). Hypotheses are that: (1) participants in the FBBI condition will lose more weight (and reduced BMI) than participants in the waitlist treatment condition, and that (2) participants in the Maintenance condition will maintain weight lost (and reductions in BMI) or experience less weight regain, as compared with participants who receive no further intervention following FBBI.

Primary Outcome

Adolescent/young adult participants' body weight was measured in kg using a Seca digital scale.

Conditions Studied

Interventions

  • BEHAVIORAL Family Based Behavioral Intervention
  • BEHAVIORAL Maintenance

Study Locations (1)

Massachusetts

  • University of Massachusetts Boston - Boston

Trial Details

FieldValue
Enrollment Target 31 participants
Start Date 2012-08-22
Est. Completion 2018-01-19
Phase NA

What the finished NCT02033642 record still lists

NCT02033642 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 31 participants, a relatively small participant target, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (96% lower).

The record links to 1 condition, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which Family Based Behavioral Intervention is the first listed.

NCT02033642 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT02033642 about?

NCT02033642 is a clinical study titled "A Family-Based Weight Loss Intervention for Youth With Intellectual Disability". The purpose of this randomized controlled trial is twofold. First, to examine the efficacy of a 24-session, 6-month family-based behavioral intervention (FBBI) - as compared to a waitlist FBBI group, which later receives the same FBBI - that targets weight loss in adolescents/young adults with intel...

What is the current status of trial NCT02033642?

This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2012-08-22. Estimated completion is 2018-01-19.

What conditions does trial NCT02033642 study?

This clinical trial studies the following conditions: Obesity.

What interventions are being tested in trial NCT02033642?

The interventions under investigation include: Family Based Behavioral Intervention (BEHAVIORAL), Maintenance (BEHAVIORAL).

Who is sponsoring clinical trial NCT02033642?

This trial is sponsored by University of Massachusetts, Boston, which has 18 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02033642 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02033642's enrollment target sits among peer trials

31 847th of 1053 higher than 204 of 1,053 other Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02932618 · 31 participants · Phase 3

    A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)

  • NCT03482297 · 31 participants · Phase 1

    Automated Abdominal Binder for Orthostatic Hypotension

  • NCT04016389 · 31 participants · NA

    FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery

  • NCT04211675 · 31 participants · Phase 1

    NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02033642, the US trial registry maintained by the National Library of Medicine. NCT02033642 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.